A living donor liver transplant is a surgical procedure in which a portion of a healthy person's liver is removed and transplanted into a recipient whose liver is failing. The donor's liver regenerates to full size within weeks, and the transplanted segment grows to restore function in the recipient. This approach reduces wait times and improves survival rates compared to deceased-donor transplants.
Liver failure due to cirrhosis, acute liver failure, or inherited metabolic diseases often requires transplantation. When waiting lists are long, living donation offers a faster solution. The procedure is performed under general anesthesia and typically takes 6 to 8 hours. Both donor and recipient undergo extensive medical screening to ensure compatibility and safety.
The United Network for Organ Sharing (UNOS) reports that over 17,000 liver transplants were performed in the U.S. between 2010 and 2020, with approximately 15% involving living donors. The majority of living donor transplants occur between related individuals, though non-related and altruistic donors are increasingly common.
During a living donor liver transplant, surgeons remove about 40-60% of the donor's liver-typically the right lobe, which contains more functional tissue. The remaining portion regrows to near full size within 6 to 8 weeks. The transplanted segment is implanted into the recipient, where it integrates and begins producing bile and filtering toxins.
Donor surgery uses laparoscopic or open techniques. Open surgery allows better visualization and control during complex vascular connections. The recipient's diseased liver is removed, and the new liver is connected to blood vessels and bile ducts. Post-op monitoring ensures proper blood flow and bile drainage.
Recovery timelines differ. Donors usually stay in the hospital 5 to 7 days and return to normal activities in 6 to 8 weeks. Recipients may require longer hospitalization-up to 2 weeks-and take immunosuppressants indefinitely to prevent rejection.
Eligible donors must be between 18 and 60 years old, in excellent physical and mental health, and have a compatible blood type with the recipient. They must also have a liver volume sufficient to allow safe removal of a functional segment.
Screening includes imaging (CT angiography, MRI), blood tests, psychological evaluation, and consultations with transplant hepatologists and surgeons. The American Society of Transplantation notes that donors must understand the risks, including bleeding, infection, and rare complications such as bile leaks or death.
Donors cannot be paid under federal law. The National Organ Transplant Act (NOTA) prohibits financial incentives for organ donation. All medical costs related to donation are covered by the recipient's insurance or transplant center.
There are two primary configurations based on anatomical division:
| Type | Donor Liver Segment | Recipient Compatibility | Use Case |
|---|---|---|---|
| Right Lobe | Approx. 60% of liver | Most adults, children with large bodies | Standard for adult recipients |
| Left Lobe | Approx. 40% of liver | Children, small adults, patients with limited space | Preferred for pediatric cases |
Left lobe transplants are more technically demanding due to smaller vessel sizes but offer lower risk to the donor. Right lobe grafts provide greater functional capacity and are associated with higher success rates in adult recipients.
Split-liver transplants-where one deceased donor liver is divided between two recipients-are distinct from living donor procedures. Living donation avoids the risk of organ discard due to cold ischemia time, a major issue in deceased donor transplants.
Many assume that donating a liver causes permanent damage. This is false. The liver regenerates completely in both donor and recipient. A 2021 study published in *The Lancet* found that 98% of living donors had full liver function restoration at 6 months post-surgery.
Another misconception is that donors face high mortality. The risk is low: the American Association for the Study of Liver Diseases (AASLD) reports a donor mortality rate of less than 0.1% in centers with experienced teams. Most deaths result from rare complications like pulmonary embolism or severe bleeding.
Some people believe the procedure is only for family members. While most donors are relatives, many hospitals accept altruistic donors-individuals who donate to strangers through paired exchange programs. These programs match incompatible donor-recipient pairs with others in similar situations, increasing donation rates.
In 2022, a 42-year-old man with advanced hepatitis B-related cirrhosis received a left lobe transplant from his sister. Pre-transplant evaluations confirmed her blood type (O), negative crossmatch, and adequate liver volume. She underwent laparoscopic surgery, and her liver regenerated fully by week 8.
The recipient was discharged home on day 10. His bilirubin levels normalized within 3 weeks, and he returned to work by month 5. Follow-up imaging at 12 months showed normal liver architecture and no signs of rejection. He remains on tacrolimus and regular monitoring.
This case reflects the typical outcome: high survival rates, rapid recovery, and improved quality of life. The 1-year survival rate for living donor recipients exceeds 90%, according to UNOS data.
Living donor transplantation is not suitable for everyone. Patients with active infections, uncontrolled cancer, or severe heart disease may be ineligible. Donors with obesity, hypertension, or prior abdominal surgery face higher surgical risks.
For example, a 55-year-old woman with fatty liver disease and BMI 38 was deemed too high-risk for donation. Her potential donor status was declined after CT scan revealed significant steatosis (fat accumulation) in the liver, reducing viability of the graft.
What is a living donor liver transplant? It is a life-saving procedure that enables faster treatment for end-stage liver disease. With careful donor selection, advanced surgical techniques, and ongoing follow-up, both donor and recipient can achieve excellent outcomes. The procedure exemplifies how human generosity, guided by medical science, can restore health and extend life.